Meningococcal Disease
Andrew J. Pollard ยท Martin C.J. Maiden
แแแ. 2008 ยท Methods in Molecular Medicine แฌแแแแ 67 ยท Springer Science & Business Media
แแแฌแแแแ
721
แแแแ แแ
reportแ แแแขแแแแแแ แแ แแแแแฎแแแแแแ แแแฃแแแกแขแฃแ แแแแแแ ย แจแแแขแงแแแ แแแขแ
แแ แแแฌแแแแแก แจแแกแแฎแแ
Meningococcal septicemia and meningitis continue to be important causes of devastating illness, death, and long-term disability in both developed and resource-poor countries of the world. Few diseases have attracted as much public attention, or are as feared by parents and family members, as well as the medical staff who have to care for affected patients. The unexpected and unp- dictable occurrence of the disease in previously healthy children and young adults, its rapid progression, and the frequent occurrence of purpura fulminans with the resulting gangrene of limbs and digits and the requirement for mutilating s- gery, have all heightened both public and medical interest in the disease. Over the past two decades there has been a rapid increase in knowledge of many aspects of meningococcal disease as a result of intensive efforts by workers in many different fields: clinicians have studied the early presenting features and acute pathophysiology of the disorder; clinical scientists have explored the immunopathological mechanisms responsible for disease and have highlighted the important roles played by the host inflammatory response and pro-inflammatory cytokines in mediating damage to blood vessels and organs; microbiologists have developed new diagnostic methods; public health phy- cians and epidemiologists have improved surveillance techniques with the help of molecular tools provided by bacterial population biologists; and basic sci- tists have used the powerful new tools in molecular and cell biology to elucidate virulence mechanisms.
แจแแแคแแกแแ แแก แแแฌแแแแ
แแแแแฎแแ แแ แแฅแแแแ แแแ แ.
แแแคแแ แแแชแแ แฌแแแแแฎแแแกแแแ แแแแแแจแแ แแแแ
แกแแแ แขแคแแแแแ แแ แขแแแแแขแแแ
แแแแแแกแขแแแแ แแ Google Play Books แแแ Android แแ iPad/iPhone แแแฌแงแแแแแแแแแแกแแแแก. แแก แแแขแแแแขแฃแ แแ แแแแแฎแแ แชแแแแแแก แกแแแฅแ แแแแแแชแแแก แแฅแแแแก แแแแแ แแจแแแ แแ แกแแจแฃแแแแแแก แแแแชแแแ, แฌแแแแแแฎแแ แกแแกแฃแ แแแแ แแแแขแแแขแ แแแแแกแแแแ แแแแแแแก, แ แแแแ แช แแแแแแ, แแกแ แฎแแแแแ แแจแ แ แแแแแจแ.
แแแแขแแแแแ แแ แแแแแแฃแขแแ แแแ
Google Play-แจแ แจแแซแแแแแ แแฃแแแแฌแแแแแแแก แแแกแแแแ แแฅแแแแ แแแแแแฃแขแแ แแก แแแ-แแ แแฃแแแ แแก แแแแแงแแแแแแ แจแแแแซแแแแ.
แแแฌแแแแแแฎแแแแแแ แแ แกแฎแแ แแแฌแงแแแแแแแแแ
แแแแฅแขแ แแแฃแแ แแแแแแก แแแฌแงแแแแแแแแแแ แฌแแกแแแแแฎแแ, แ แแแแ แแชแแ Kobo eReaders, แแฅแแแ แฃแแแ แฉแแแแขแแแ แแแ แคแแแแ แแ แแแแแแขแแแแ แแแ แแฅแแแแก แแแฌแงแแแแแแแแจแ. แแแฎแแแ แแแแก แชแแแขแ แแก แแแขแแแฃแ แ แแแกแขแ แฃแฅแชแแแแแก แแแฎแแแแแ แแแแแแขแแแแ แคแแแแแแ แแฎแแ แแแญแแ แแ แแแฌแแแแแแฎแแแแแแแ.
